About Asimov
Asimov is a company based in Boston (United States) founded in 2017.. Asimov has raised $209.4 million across 9 funding rounds from investors including Fidelity Investments, CPP Investments and KdT Ventures. The company has 87 employees as of December 31, 2023. Asimov offers products and services including CHO Edge System, LV Edge System, AAV Edge System, and Design Software. Asimov operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
- Headquarter Boston, United States
- Employees 87 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Asimov Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$209.4 M (USD)
in 9 rounds
-
Latest Funding Round
$175 M (USD), Series B
Jan 05, 2023
-
Investors
Fidelity Investments
& 10 more
-
Employee Count
87
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Asimov
Asimov offers a comprehensive portfolio of products and services, including CHO Edge System, LV Edge System, AAV Edge System, and Design Software. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for producing biologics with high titers.
Enables lentiviral production for therapeutic applications.
Facilitates gene therapy payload design and production.
Cloud-based tool for simulating and optimizing genetic systems.
Unlock access to complete
Unlock access to complete
Funding Insights of Asimov
Asimov has successfully raised a total of $209.4M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $175 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series B — $175.0M
-
First Round
First Round
(04 Apr 2017)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Series B - Asimov | Valuation | CPP Investments | |
| Jun, 2020 | Amount | Series A - Asimov | Valuation | Horizons Ventures |
|
| May, 2019 | Amount | Post-IPO - Asimov | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Asimov
Asimov has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, CPP Investments and KdT Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in frontier science ventures.
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
Early-stage centric tech-focused VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Asimov
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Asimov
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Asimov Comparisons
Competitors of Asimov
Asimov operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Asimov
Frequently Asked Questions about Asimov
When was Asimov founded?
Asimov was founded in 2017.
Where is Asimov located?
Asimov is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Asimov a funded company?
Asimov is a funded company, having raised a total of $209.4M across 9 funding rounds to date. The company's 1st funding round was a Post-IPO of $6.86M, raised on Apr 04, 2017.
How many employees does Asimov have?
As of Dec 31, 2023, the latest employee count at Asimov is 87.
What does Asimov do?
Asimov was founded in 2017 and is headquartered in Boston, United States. An end-to-end platform is offered in the synthetic biology sector, combining computational tools with biological engineering. Engineered host cells, genetic parts libraries, and design software are provided as key components. Cell line development, genetic construct design, and data analysis are enabled through the system, with operations centered on biotechnology applications.
Who are the top competitors of Asimov?
What products or services does Asimov offer?
Asimov offers CHO Edge System, LV Edge System, AAV Edge System, and Design Software.
Who are Asimov's investors?
Asimov has 11 investors. Key investors include Fidelity Investments, CPP Investments, KdT Ventures, Casdin Capital, and Pillar VC.